News

Month Year

Month Year

Apr 24, 2020

DUPIXENT® (dupilumab) receives positive recommendation from CADTH for moderate-to-severe atopic dermatitis
Apr 14, 2020

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
Apr 2, 2020

First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
Mar 2, 2020

Cablivi® (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura (aTTP)
Jan 30, 2020

Sanofi Canada named a Top Employer in Montreal for 2020, the third similar recognition in the last six months
Nov 22, 2019

Sanofi Canada named one of Canada's Top 100 Employers for 2020
Oct 22, 2019

Patients in Quebec now have access to DUPIXENT™ for the treatment of moderate-to-severe atopic dermatitis
Oct 18, 2019

Sanofi to conduct precautionary voluntary recall of Zantac OTC in Canada and the U.S.
- Photos 1
Oct 1, 2019

"Pillars of Strength" photo exhibit opens to celebrate National Seniors Day with compelling images of Canadian Seniors
Sep 27, 2019

Health Canada approves Dupixent™ as the first biologic for the treatment of adolescents with moderate-to-severe atopic dermatitis
Sep 26, 2019

Sanofi Canada receives Gold-Level Parity Certification
- Photos 1
Jun 11, 2019

Canadian employers underestimate the presence of chronic disease in the workforce
Apr 11, 2019

Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC)
Oct 17, 2018

Canadians are invited to join the conversation: Raise Your Hand for Diabetes
Oct 1, 2018

Sanofi aims to topple the flu as it marks National Seniors Day with a Guinness World Record attempt
Sep 27, 2018

Canadians living with diabetes in Ontario and Manitoba now have greater access to diabetes medicine
Sep 25, 2018

Health Canada approves Lovenox® for the prevention of blood clot formation in the extra-corporeal circulation during hemodialysis in patients with end stage kidney disease (ESKD)

Studies show that Lovenox® (enoxaparin sodium) is an alternative to conventional heparin in preventing clotting during hemodialysis
Jul 10, 2018

Sanofi denounces CADTH negative recommendation that could limit treatment options for Canadians with atopic dermatitis
Jul 3, 2018

Three Canadian Researchers Receive Sanofi–CARO Award for Research in Prostate Cancer Therapies
Jun 27, 2018

Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec
Jun 22, 2018

Sanofi Canada Lends Support in the Fight to Eradicate Tuberculosis in Canada
Jun 13, 2018

Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact
Jun 8, 2018

Canadian science prodigy winner of prestigious international competition
May 16, 2018

Canadians living with diabetes can now access a new resource to help better manage their disease
Apr 12, 2018

Sanofi to invest €350 million in Canadian vaccine facility

Show per page